Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
70.12
-0.10 (-0.14%)
Apr 2, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.98 billion as of April 2, 2026. Its market cap has increased by 44.74% in one year.
Market Cap
2.98B
Enterprise Value
2.65B
1-Year Change
44.74%
Ranking
Category
Stock Price
$70.12
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.98B, an increase of 868.42%. That is a compound annual growth rate of 51.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.98B | -14.14% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.27B |
| Dyne Therapeutics | 3.11B |
| Tango Therapeutics | 3.09B |
| Telix Pharmaceuticals | 3.03B |
| Catalyst Pharmaceuticals | 3.02B |
| Alumis | 2.97B |
| Arcutis Biotherapeutics | 2.93B |
| Vera Therapeutics | 2.92B |